ScinoPharm to Provide API to Supernus Pharmaceuticals

January 30th 2025

Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain

The reduction is expected to be “substantially completed,” the San Diego-based company said, in the second quarter of 2025.

Jill Murphy

November 14th 2023

Podcast

In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

European Drug Shortage Monitoring Platform Fully Operational

Susan Haigney

January 29th 2025

Lantheus Announces Agreement to Acquire Evergreen Theragnostics

The platform is live with full functionality for use by marketing authorization holders and national competent authorities to report drug supply information.

Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept. | Image Credit: © Dilok - stock.adobe.com

European Commission Approves Johnson & Johnson Non-Small Cell Lung Cancer Treatment

The deal is being made for an all-cash price of $250 million, but with an additional $752.5 million available in potential milestone payments.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

AstraZeneca Makes Investment to Create 700 High-Skilled Jobs in Greater Toronto Area

Data from a Phase III study that evaluated lazertinib, in combination with amivantamab, in comparison to osimertinib as a first-line treatment resulted in the EC’s decision.

Zentalis to Cut 40% of Workforce Under Strategic Restructuring Plan

The company’s investments in Canada since 2023 have now resulted in the creation, or potential thereof, of 1200 new job positions.

Related Content

January 30th 2025

Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain

The reduction is expected to be “substantially completed,” the San Diego-based company said, in the second quarter of 2025.

Jill Murphy

November 14th 2023

Podcast

European Drug Shortage Monitoring Platform Fully Operational

Susan Haigney

January 29th 2025

Lantheus Announces Agreement to Acquire Evergreen Theragnostics

The platform is live with full functionality for use by marketing authorization holders and national competent authorities to report drug supply information.

European Commission Approves Johnson & Johnson Non-Small Cell Lung Cancer Treatment

The deal is being made for an all-cash price of $250 million, but with an additional $752.5 million available in potential milestone payments.

AstraZeneca Makes Investment to Create 700 High-Skilled Jobs in Greater Toronto Area

Data from a Phase III study that evaluated lazertinib, in combination with amivantamab, in comparison to osimertinib as a first-line treatment resulted in the EC’s decision.